Equibles does not estimate personal net worth.
Earlier roles on record: CFO at Ocugen, Inc. (OCGN) until March 18, 2022. The proxy statement of Ocugen, Inc. reports total compensation of $2,602,661 for Sanjay Subramanian in fiscal 2021, including a base salary of $385,000. Disclosed compensation is on record for 2 fiscal years. Sanjay Subramanian has spoken on 6 earnings calls across 1 company, most recently for Ocugen, Inc. on February 25, 2022. The companies whose calls Sanjay Subramanian spoke on are classified in the Healthcare sector.
“I will now provide an overview of key financial results for the fourth quarter and full year of 2021. Our research and development expenses for the quarter ended December 31, 2021, were $7.1 million, compared to $1.6 million for the fourth quarter ended December 31, 2020.”
“I will now provide an overview of key results for the third quarter of this year. Our research and development expenses for the quarter ended September 30, 2021, were $6.3 million, compared to $1.5 million for the same quarter ended September 30, 2020.”
“I will now provide an overview of key financial results for the second quarter of this year. We ended the quarter with cash, cash equivalents, and restricted cash totaling $115.8 million as of June 30, 2021 compared to $24.2 million on hand as of December 31, 2020.”
“We have made significant strides in the first quarter of this year, particularly in working to bring COVAXIN to the U.S. market with the submission of our comprehensive drug Master File with the FDA.”
“As Shankar mentioned before, 2020 has been a very eventful year for Ocugen and has broadened our mission to cure blindness diseases and save lives from COVID-19.”
Start not stated–2022-03-18
OCGN
Biotechnology · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Ocugen, Inc. (OCGN) | Former Chief Financial Officer, Head of Corporate Development, and Corporate Secretary | $385,000 | $2,602,661 |
| 2020 | Ocugen, Inc. (OCGN) | Former Chief Financial Officer, Head of Corporate Development, and Corporate Secretary | $365,400 | $661,790 |
